The ASyMS-CCC Study: Phase II
Research type
Research Study
Full title
IMPROVING THE QUALITY AND OUTCOMES OF CARE FOR PATIENTS WITH BREAST OR COLORECTAL CANCER RECEIVING CHEMOTHERAPY: THE ADVANCED SYMPTOM MANAGEMENT SYSTEM: PHASE II
IRAS ID
129606
Contact name
Roma Maguire
Contact email
Sponsor organisation
University of Surrey
Research summary
Many people receive chemotherapy and can experience unpleasant and distressing side effects which can impact on their quality of life. The majority of chemotherapy is given on an outpatient basis therefore patients are often required to manage the side effects they encounter at home without much direct supervision from health care professionals. This study aims to explore the impact of a mobile phone based, remote monitoring, symptom management intervention (ASyMS) on the delivery of care to people with either colorectal or breast cancer receiving chemotherapy. This is a two phase study. Phase I was the development phase and phase II is the implementation phase of the study. This ethics application refers to Phase II only.
Phase II of the study will assess the feasibility and acceptability of ASyMS to monitor and manage chemotherapy-related symptoms in people with breast or colorectal cancer experience. ASyMS will be used by patients and health care professionals in the Clatterbridge Cancer Centre NHS Foundation Trust. The overall aim of the study is to evaluate the impact of a remote monitoring Advanced Symptom Management System (ASyMS) on the care delivered to people with breast and colorectal cancer receiving chemotherapy.
REC name
West of Scotland REC 3
REC reference
14/WS/1045
Date of REC Opinion
18 Sep 2014
REC opinion
Further Information Favourable Opinion